RECRUITING

Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Patients with cancer have a higher incidence of AF but despite the higher incidence of AF in the cancer population, there are no randomized controlled trials (RCTs) for AF screening in this population. RCTs of AF screening in the general population have shown that screening can effectively detect AF earlier, and helps to identify candidates for appropriate anticoagulation that may lead to improvement in clinical outcomes.

Official Title

Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial

Quick Facts

Study Start:2023-11-06
Study Completion:2025-07-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05784766

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male and female patients age ≥65 with a current diagnosis or history of cancer.
  2. 2. Patients currently undergoing or history of chemotherapy, radiotherapy or cancer related surgeries will be included.
  3. 3. The age is restricted to ≥65 years because prevalence of AF is extremely low. .
  1. 1. Known history of atrial fibrillation.
  2. 2. Non-English-speaking participants will not be enrolled

Contacts and Locations

Study Contact

Aurora Vera, RMA
CONTACT
405-271-9060
Aurora-vera@ouhsc.edu
Zain Asad, MD
CONTACT
405-271-4742
ZainUlAbideen.Asad@ouhealth.com

Principal Investigator

Zain Asad, MD
PRINCIPAL_INVESTIGATOR
OU Health

Study Locations (Sites)

University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
United States

Collaborators and Investigators

Sponsor: University of Oklahoma

  • Zain Asad, MD, PRINCIPAL_INVESTIGATOR, OU Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-06
Study Completion Date2025-07-30

Study Record Updates

Study Start Date2023-11-06
Study Completion Date2025-07-30

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer